Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Effron

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Mayo Clinic Proceedings|June 6, 2022
Importance of More Potent Antiplatelet Therapy in Myocardial Infarction With Cardiac Arrest or Cardiogenic ShockMark B Effron
Mayo Clinic Proceedings|December 4, 2022
Racial Disparities and Excess Cardiovascular Mortality Before and During the COVID-19 Pandemic: Time for a SolutionKoyenum Obi, Mark B Effron
Expert Review of Cardiovascular Therapy|August 3, 2025
Clinical utility of platelet FcγRIIa as a cardiovascular risk marker in patients in acute myocardial infarctionAhmad Hallak, Mark B Effron
Journal of the Society for Cardiovascular Angiography & Interventions|April 29, 2026
Humanity Amid ConflictAhmad Hallak, Mark B Effron
Mayo Clinic Proceedings|November 3, 2023
More Potent Antiplatelet Therapy in Acute Coronary Syndrome Patients With Prior Stroke: Proceed With Caution?Christopher M McKinnie, Mark B Effron
Progress in Cardiovascular Diseases|January 26, 2018
The Waxing and Waning of Antithrombotic Therapy in Cardiovascular Disease - Where Is the Moon Now?Mark B Effron, C Michael Gibson
Progress in Cardiovascular Diseases|January 24, 2018
Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" ExperienceMark B Effron, C Michael Gibson
Journal of Critical Care|May 4, 2010
A prospective, observational study of Xigris Use in the United States (XEUS)Jay S Steingrub, Michael L Cheatham, Brad Woodward, et al.
Seminars in Thrombosis and Hemostasis|June 23, 2022
Proposal for a Simple Algorithmic Approach to Manage Drug-Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 OutpatientsJohn G Rizk, Jose G Lazo, Aashish Gupta, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Characteristics and Predictors of Apparent Treatment Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based DataEissa Jafari, Rhonda M Cooper-DeHoff, Mark B Effron, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Mayo Clinic Proceedings|June 6, 2022
Importance of More Potent Antiplatelet Therapy in Myocardial Infarction With Cardiac Arrest or Cardiogenic ShockMark B Effron
Mayo Clinic Proceedings|December 4, 2022
Racial Disparities and Excess Cardiovascular Mortality Before and During the COVID-19 Pandemic: Time for a SolutionKoyenum Obi, Mark B Effron
Expert Review of Cardiovascular Therapy|August 3, 2025
Clinical utility of platelet FcγRIIa as a cardiovascular risk marker in patients in acute myocardial infarctionAhmad Hallak, Mark B Effron
Journal of the Society for Cardiovascular Angiography & Interventions|April 29, 2026
Humanity Amid ConflictAhmad Hallak, Mark B Effron
Mayo Clinic Proceedings|November 3, 2023
More Potent Antiplatelet Therapy in Acute Coronary Syndrome Patients With Prior Stroke: Proceed With Caution?Christopher M McKinnie, Mark B Effron
Progress in Cardiovascular Diseases|January 26, 2018
The Waxing and Waning of Antithrombotic Therapy in Cardiovascular Disease - Where Is the Moon Now?Mark B Effron, C Michael Gibson
Progress in Cardiovascular Diseases|January 24, 2018
Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" ExperienceMark B Effron, C Michael Gibson
Journal of Critical Care|May 4, 2010
A prospective, observational study of Xigris Use in the United States (XEUS)Jay S Steingrub, Michael L Cheatham, Brad Woodward, et al.
Seminars in Thrombosis and Hemostasis|June 23, 2022
Proposal for a Simple Algorithmic Approach to Manage Drug-Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 OutpatientsJohn G Rizk, Jose G Lazo, Aashish Gupta, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Characteristics and Predictors of Apparent Treatment Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based DataEissa Jafari, Rhonda M Cooper-DeHoff, Mark B Effron, et al.
Pageof 10